江蘇北人(688218.SH)將於12月11日在科創板上市
格隆匯12月9日丨江蘇北人(688218.SH)發佈首次公開發行股票科創板上市公告書,發行數量為2934萬股,每股發行價為17.36元;將於2019年12月11日在上海證券交易所科創板上市。
此次發行價格為17.36元/股,對應的市盈率為44.67倍(每股收益按照2018年度經審計的扣除非經常性損益前後孰低的歸屬於母公司淨利潤除以本次發行後總股本計算)。
2019年1-9月營業收入約3.08億元,同比上升16.67%;淨利潤為3208.58萬元,同比下降4.83%;歸屬於母公司股東的淨利潤為3224.32萬元,同比上升0.55%;扣除非經常性損益後的歸屬於母公司股東的淨利潤為2884.19萬元,同比下降3.93%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.